Adage Capital Partners Gp, L.L.C. Vertex Pharmaceuticals Inc Transaction History
Adage Capital Partners Gp, L.L.C.
- $54.6 Billion
- Q3 2024
A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 346,355 shares of VRTX stock, worth $141 Million. This represents 0.29% of its overall portfolio holdings.
Number of Shares
346,355
Previous 335,161
3.34%
Holding current value
$141 Million
Previous $157 Million
2.54%
% of portfolio
0.29%
Previous 0.3%
Shares
29 transactions
Others Institutions Holding VRTX
# of Institutions
1,726Shares Held
221MCall Options Held
1.58MPut Options Held
1.36M-
Capital World Investors Los Angeles, CA26.8MShares$10.9 Billion1.99% of portfolio
-
Vanguard Group Inc Valley Forge, PA23.2MShares$9.43 Billion0.2% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$8.68 Billion0.23% of portfolio
-
State Street Corp Boston, MA11.8MShares$4.81 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA9MShares$3.66 Billion0.9% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $105B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...